Dose prediction for repurposing nitazoxanide in SARS‐CoV‐2 treatment or chemoprophylaxis is a research paper published in British Journal of Clinical Pharmacology (2020). On theSindex it has a DataRank of 0. It has been cited 58 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Medical Research Council Canada
Grant: MR/S00467X/1
MICA: New combination therapy against MDR TB targeting the respiratory chain
European Commission
Grant: 761104
Regulatory Science Framework for Nano(bio)material-based Medical Products and Devices
National Institutes of Health
Grant: R24AI118397
National Institutes of Health
Grant: R01AI134091
Engineering and Physical Sciences Research Council
Grant: EP/S012265/1
An Injectable Implant Providing Long-Acting Drug Delivery for the Treatment of Chronic disease
Engineering and Physical Sciences Research Council
Grant: EP/R024804/1
New Branched Polymers Excipients and Emulsions for Enhanced Drug Delivery
Economic and Social Research Council
Grant: SIPF00005/1
Wellcome Trust
Grant: 221590/Z/20/Z
Medical Research Council
Grant: MC_PC_17167
Medical Research Council
Grant: MR/V028391/1
Medical Research Council
Grant: MC_PC_17225
National Institutes of Health
Grant: 5R24AI118397-10
The Long-Acting/Extended Release Antiretroviral Resource Program (LEAP)
National Institutes of Health
Grant: 5R24AI118397-07
The Long-Acting/Extended Release Antiretroviral Resource Program (LEAP)
National Institutes of Health
Grant: 5R01AI134091-05
Long acting NRTI therapies for HIV
MeSH Terms
Keywords
Sustainable Development Goals